BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoingPublic.de - ECPv6.16.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GoingPublic.de
X-ORIGINAL-URL:https://www.goingpublic.de
X-WR-CALDESC:Veranstaltungen für GoingPublic.de
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251007
DTEND;VALUE=DATE:20251009
DTSTAMP:20241205T095828Z
CREATED:20241205T095828Z
LAST-MODIFIED:20241205T095828Z
UID:148749-1759827600-1759913999@www.goingpublic.de
SUMMARY:12th Annual HealthTech Investment Forum
DESCRIPTION:Sachs Associates would like to say that we have enjoyed hosting you in person and virtually and  thank those who participated in our Sachs Autumn Life Sciences Week\, which incorporated the 11th Annual HealthTech Investment Forum (#Sachs_HTIF) and the 24th Annual Biotech in Europe Forum (#Sachs_BEF). A special thank you goes to the excellent lineup of sponsors\, chairs\, panellists\, and presenters who made such a broad and interesting programme possible and to those who participated in person and during the virtual week. \nThe Life Sciences Week has proven to be successful in supporting our community with 589 delegates from 32 countries and over 2500 in-person & online meetings completed. \nPublicly available recordings of the sessions and presentations that took place during the event will be added once the event portal closes (after the 25th of October) on the SachsTV YouTube channel. \nWe are looking forward to welcoming you again at our future events! \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nKeynote Speakers Included: \n\nRuthy Kaidar\, Managing Director Healthcare\, EMEA\, Microsoft Corporation\nJeffrey Cohen\, Director of Research\, Ladenburg Thalmann & Co. Inc.\n\nChairs & Speakers Included: \n\nAli Tinazli\, CEO\, Lifespin GmbH\nAndreas Wüpper\, Managing Director\, Fresenius Medical Care Ventures GmbH\nAngela Zubel\, CDO\, Debiopharm International SA\nBeat Merz\, Managing Director\, New Harbor Venture Partners\, LLC\nBeatriz Volckaert\, Principal\, Philips Ventures\nBoris Bogdan\, Lead HCLS EMEA\, Amazon Web Services\nBracy Fertig\, VP Strategy & Corporate Development \, Caresyntax Corp.\nCem Baydar\, Chief Investment Officer\, Eczacibasi Pharmaceutical and Industrial Investment Co.\nChristian Hein\, Executive Advisor & Board Member\, Quant Health\nChristian Kannemeier\, Sr. Investment Manager\, High-Tech Gründerfonds\nChristian Schenk\, Investment Director\, Apposite Capital LLP\nDaniel Parera\, Partner\, Kurma Partners\nDiana Saraceni\, Co-Founder & General Partner\, Panakès Partners SGR SpA\nEdouard Gobitz\, Managing Partner\, Asklepios Advisors\nEli Yered\, CFO\, Sanara Ventures\nElie Lobel\, CEO\, RDS SAS\nEric de La Fortelle\, Managing Partner\, Cathay Health\nEyal Lifschitz\, Co-Founder & General Managing Partner\, Peregrine Ventures\nFilippo Piatti\, Co-Founder & CEO\, Artiness S.r.l\nGiancarlo Rizzoli\, CEO\, 4D Lifetec AG\nIsaac Middelmann\, Accelerator Director – Strategic Fundraising\, EIT Health e.V.\nJean-Pierre Pennacino\, CFO\, MedAlliance SA\nKatrin Vatiska\, Investment Partner\, MTIP AG\nKonrad Dobschuetz\, Global HealthTech Leader\, former National Director NHS Innovation Accelerator\, Independent\nLaurent Choppe\, Managing Partner\, Cukierman & Co. Life Sciences\nLeo Smit\, CEO\, Hy2Care B.V.\nMarco Wendel\, Managing Director\, Medical Valley EMN e.V.\nMarianne Mertens\, Partner\, Apollo Health Ventures\nMarina Izzo\, CEO\, EBAMed SA\nRainer Metzger\, Head of Integrated Clinical Services\, Medicover AB\nRemi Spagnol\, Investment Director\, Supernova Invest\nRoman Schenk\, Managing Partner\, INOGROUP GmbH\nRuthy Kaidar\, Managing Director Healthcare\, EMEA\, Microsoft Corporation\nSarah Des Rosiers\, Director\, Health Equity\, Novartis Foundation\nStephan Wehrli\, Investment Principal & Partner\, Zühlke Ventures AG\nTamara Gerbert\, Founder\, VP of Strategy & Director of Neuroscience\, Brightmind.AI GmbH\nTanja Dowe\, Managing Director\, Angelini Ventures S.p.A.\nTodor Jeliaskov\, Chairman & CEO\, inHEART\nUlrich Muehlner\, Co-Founder & CEO\, GrowthCube Partners LLC
URL:https://www.goingpublic.de/event/12th-annual-healthtech-investment-forum/
LOCATION:Mövenpick Hotel Basel\, Aeschengraben 25\, 4051\, Schweiz
CATEGORIES:Life Sciences
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251008
DTEND;VALUE=DATE:20251011
DTSTAMP:20241205T100529Z
CREATED:20241205T100529Z
LAST-MODIFIED:20241205T100529Z
UID:148752-1759914000-1760086799@www.goingpublic.de
SUMMARY:25th Annual Biotech in Europe Forum
DESCRIPTION:Sachs Associates would like to say that we have enjoyed hosting you in person and virtually and thank those who participated in our Sachs Autumn Life Sciences Week\, which incorporated the 11th Annual HealthTech Investment Forum (#Sachs_HTIF) and the 24th Annual Biotech in Europe Forum (#Sachs_BEF). A special thank you goes to the excellent lineup of sponsors\, chairs\, panellists\, and presenters who made such a broad and interesting programme possible and to those who participated in person and during the virtual week. \nThe Life Sciences Week has proven to be successful in supporting our community with 589 delegates from 32 countries and over 2500 in-person & online meetings completed. \nPublicly available recordings of the sessions and presentations that took place during the event will be added once the event portal closes (after the 25th of October) on the SachsTV YouTube channel. \nWe are looking forward to welcoming you again at our future events! \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nKeynote Speakers Included: \n\nGregory Rall\, Deputy Head\, Innovation & Technology\, InvestHK\nLaura Lane\, VP\, Lilly Ventures – Europe Head External Innovation\, Eli Lilly and Company\nLukas Engelberger\, State Councillor\, Department of Public Health\, Canton of Basel-Stadt\nFireside Discussion: „How I Took a European Biotech to a Billion-Dollar Exit“ With: Renée Aguiar-Lucander\, CEO\, Calliditas Therapeutics AB\n\nConfirmed Speakers & Chairs Included: \n\nAlessandra Polara\, Senior Director\, Global BD\, F. Hoffmann-La Roche AG\nAlex Blyth\, CEO\, LIfT BioSciences Ltd.\nAnders Bue Klein\, Co-Founder & CEO\, Ousia Pharma ApS\nAntoine Boulanger\, Principal\, Forbion\nAntti Vuolanto\, CEO\, Herantis Pharma Plc\nAram Mangasarian\, CEO\, TME Pharma\nAsun Monfort\, Investment Advisor\, HBM Partners AG\nBerthold Hinzen\, Global Head BD&L Transactions Immunology\, Novartis AG\nCarlos Buesa\, Founder & CEO\, Oryzon Genomics\, S.A.\nChristoph Korpus\, Director Global Business Development & Licensing Oncology\, Merck KGaA\, Darmstadt\, Germany\nCindy Daniel\, Head of Unit – Life Sciences & Healthcare – Equity Investments\, European Investment Fund\nDarren Ji\, Co-Founder\, Chairman & CEO\, Elpiscience Biopharmaceuticals Co. Ltd.\nDimitrios Weedon-Topalopoulos\, Managing Director\, OrbiMed Advisors LLC\nDragan Grabulovski\, Founder & CEO\, Grabulovski Consulting Services GmbH\nEdward van Wezel\, Managing Partner\, BioGeneration Ventures\nEric Halioua\, President & CEO\, PDC*line Pharma SA\nEsteban Pombo-Villar\, CTO\, TargImmune Therapeutics AG\nFederico Bolognani\, Chief Medical Officer\, IAMA Therapeutics S.r.l.\nFrançois Thomas\, Operating Partner\, Quadrille Capital\nFrank Grams\, Chief Commercial Officer\, Partex N.V.\nGregory Rall\,  Deputy Head\, Innovation & Technology\, InvestHK\nHelen Chen\, Global Sector Co-Head\, Healthcare & Life Sciences | Greater China Managing Partner\, L.E.K. Consulting\nHubert Birner\, Managing Partner\, TVM Capital Life Science\nIsabella Schidrich\, Senior Managing Director\, Listings EMEA\, Nasdaq\nJeremy Griggs\, Executive Director\, Search & Evaluation\, GSK\nJesus Baena\, BD&L Transactions Director\, Novartis AG\nJoachim Vogt\, Director Search & Evaluation International\, AbbVie\, Inc.\nJosua Jordi\, Discovery Area Lead in Metabolism\, F. Hoffmann-La Roche AG\nKatharina Kreymborg\, SVP\, Curie.Bio\nKeld Flintholm Jørgensen\, SVP & CBO\, H. Lundbeck A/S\nKelly Curtin\, Managing Director\, Stifel\nKonstantin Petropoulos\, CBO & Managing Director\, Secarna Pharmaceuticals GmbH & Co. KG\nKristian Tryggvason\, Founder & CEO\, Alder Therapeutics AB\nLaurent Jacqueroud\, BD & Investment Director\, Cumulus Oncology\nLouise S. Dalbøge\, Chief Science Officer\, Gubra A/S\nLynn Durham\, Founder & CEO\, STALICLA SA\nMagne Stoknes\, Principal\, Novo Holdings A/S\nMarianne Uteng\, Managing Director\, Novartis Venture Fund\nMarie Schroeder\, Vice President\, Novo Holdings A/S\nMarina Udier\, CEO\, Nouscom AG\nMatthieu Coutet\, Partner\, Sofinnova Partners\nMichael Altorfer\, CEO\, Swiss Biotech Association\nMichael Hübner\, Director Early Innovation Partnering\, Johnson & Johnson Innovation LLC\nNeil Anderson\, Head of Science2Medicine iNNvest\, Novo Nordisk A/S\nNigel Sheail\, Venture Partner\, Versant Ventures\nOlav Zilian\, Senior Financial Analyst\, Pictet & Cie\nPatrick Schwab\, Senior Director\, AI & Machine Learning\, GSK\nPaul Bravetti\, CEO\, Brenus Pharma\nPaul Hermant\, Partner\, Bird & Bird LLP\nPeter Braun\, CEO\, TargImmune Therapeutics AG\nRainer Strohmenger\, Managing Partner\, Wellington Partners\nRenée Aguiar-Lucander\, CEO\, Calliditas Therapeutics AB\nRianne Ellenbroek\, Principal\, BioGeneration Ventures\nRicardo Pacheco\, Strategic Partnering\, BD& Director\, Insilico Medicine\nRichard Ward\, Executive Director\, Search & Evaluation\, AstraZeneca\nRupert Haynes\, CEO\, Avata Biosciences\nSam Fazeli\, Head of Research\, Senior Pharmaceuticals Analyst\, Bloomberg Intelligence\nSandra von Meier\, Head Business Development & Licensing\, Debiopharm International SA\nSanja Tomovska\, Co-Founder & CEO\, Quant Biomarkers AG\nSarah Holland\, President of Swiss Healthcare Licensing Group & CBO\, Cureteq AG\nSeth Goldblum\, SVP – Corporate Development\, Cullgen Inc.\nShelley Margetson\, Managing Partner\, V-Bio Ventures B\nStephan Emmerth\, Director\, BaseLaunch\nStephane Degove\, CEO\, Atamyo Therapeutics SAS\nStephanie Léouzon\, Managing Director & Vice Chair of European Healthcare Investment Banking\, Stifel\nTamas Schweighoffer\, Co-Founding Partner\, Forty51 Ventures\nVictoria English\, Co-Founder & Editor\, Evernow Publishing Ltd\, publisher of MedNous\nXiming Ding\, Investment Manager\, Pureos Bioventures
URL:https://www.goingpublic.de/event/25th-annual-biotech-in-europe-forum/
LOCATION:Mövenpick Hotel Basel\, Aeschengraben 25\, 4051\, Schweiz
CATEGORIES:Life Sciences
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20251016T173000
DTEND;TZID=Europe/Berlin:20251016T210000
DTSTAMP:20251009T115313Z
CREATED:20251009T111021Z
LAST-MODIFIED:20251009T115313Z
UID:155230-1760635800-1760648400@www.goingpublic.de
SUMMARY:Performance − re-invented
DESCRIPTION:Was bedeutet Performance heute wirklich? \nGeht es nur um Zahlen – oder um Wirkung\, Haltung und Transformation? Als C-Level-Führungskraft wissen Sie: Wahre Performance beginnt mit einem neuen Führungsverständnis. \nEinladung zum C-Level-Abend am 16. Oktober 2025 in München:\nErleben Sie einen Abend jenseits klassischer Podiumsdiskussionen – mit vertraulichem Austausch\, echten Impulsen und Perspektiven\, die inspirieren. \nWarum Sie dabei sein sollten: \n\n\nNeuer Blick auf Performance: Wirtschaftlich\, kulturell\, menschlich – wir denken Performance ganzheitlich. \n\n\nTransformation mit Substanz: Wie gestalten Sie Wandel\, der trägt? Diskutieren Sie Wege aus der Veränderungsmüdigkeit. \n\n\nDialog auf Augenhöhe: Offen und exklusiv für C-Level – keine Pitches\, keine Show. \n\n\nImpulse & Selbstreflexion: Lernen Sie von anderen Branchen und stärken Sie Ihre Führungskultur. \n\n\nKeine Bühne für Buzzwords – sondern echte Fragen\, Erfahrungen und Inspiration für Führung mit Tiefgang. \n\nProgramm \n\n\n17:30 Uhr: Get-together \n\n\n18:00 Uhr: Panel „Wer entscheidet\, was Performance wirklich ist?“ + Q&AMit: \n\n\nUlrike Meyer\, GF Willenbrock Fördertechnik GmbH \n\n\nDr. Marlen Wienert\, Vorstand BayWa AG \n\n\nDr. Markus Fischer\, CFO CargoBeamer AG \n\n\nAstrid Schulte\, Vorstand & Gesellschafterin Behrendsohn AG \n\n\n\n\nab 19:30 Uhr: Networking & exklusive Verpflegung
URL:https://www.goingpublic.de/event/performance-%e2%88%92-re-invented/
LOCATION:Mindspace Viktualienmarkt\, Rosental 7\, München\, Bayern\, 80331\, Germany
ORGANIZER;CN="Helbling Business Advisors Deutschland":MAILTO:info-hba@helbling.de
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251023
DTEND;VALUE=DATE:20251025
DTSTAMP:20241217T162444Z
CREATED:20241205T145039Z
LAST-MODIFIED:20241217T162444Z
UID:148824-1761210000-1761296399@www.goingpublic.de
SUMMARY:Finance Day Leipzig\, 2025
DESCRIPTION:
URL:https://www.goingpublic.de/event/finance-day-2/
LOCATION:BIO CITY LEIPZIG\, Deutscher Platz 5\, Leipzig \, 04103 
CATEGORIES:Life Sciences
ATTACH;FMTTYPE=image/webp:https://www.goingpublic.de/wp-content/uploads/2024/12/Finance-Day-2025.webp
ORGANIZER;CN="Plattform Life Sciences":MAILTO:lifesciences@goingpublic.de
END:VEVENT
END:VCALENDAR